MX2009006470A - Proteina linfopoyetina estromatica timica de canino, y usos de la misma. - Google Patents

Proteina linfopoyetina estromatica timica de canino, y usos de la misma.

Info

Publication number
MX2009006470A
MX2009006470A MX2009006470A MX2009006470A MX2009006470A MX 2009006470 A MX2009006470 A MX 2009006470A MX 2009006470 A MX2009006470 A MX 2009006470A MX 2009006470 A MX2009006470 A MX 2009006470A MX 2009006470 A MX2009006470 A MX 2009006470A
Authority
MX
Mexico
Prior art keywords
protein
canine
canine tslp
thymic stromal
peptide fragments
Prior art date
Application number
MX2009006470A
Other languages
English (en)
Spanish (es)
Inventor
Daniel M Gorman
Jeanine D Mattson
Waal Malefyt Rene De
Mohamad A Morsey
Original Assignee
Schering Plough Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Plough Ltd filed Critical Schering Plough Ltd
Publication of MX2009006470A publication Critical patent/MX2009006470A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C07K14/43—Sweetening agents, e.g. thaumatin, monellin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5418—IL-7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/461—Igs containing Ig-regions, -domains or -residues form different species
    • C07K16/464—Igs containing CDR-residues from one specie grafted between FR-residues from another
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/54—Interleukins [IL]
    • G01N2333/5418—IL-7
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/20—Dermatological disorders
    • G01N2800/202—Dermatitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Toxicology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Botany (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
MX2009006470A 2006-12-14 2007-12-11 Proteina linfopoyetina estromatica timica de canino, y usos de la misma. MX2009006470A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87513506P 2006-12-14 2006-12-14
PCT/US2007/025318 WO2008076255A2 (en) 2006-12-14 2007-12-11 Canine thymic stromal lymphopoietin protein and uses thereof

Publications (1)

Publication Number Publication Date
MX2009006470A true MX2009006470A (es) 2009-06-26

Family

ID=39430681

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009006470A MX2009006470A (es) 2006-12-14 2007-12-11 Proteina linfopoyetina estromatica timica de canino, y usos de la misma.

Country Status (18)

Country Link
US (3) US7718772B2 (enExample)
EP (1) EP2104683B1 (enExample)
JP (4) JP2010512744A (enExample)
KR (1) KR101525631B1 (enExample)
CN (2) CN101631800B (enExample)
AU (1) AU2007334531B2 (enExample)
BR (1) BRPI0720001A2 (enExample)
CA (1) CA2671865C (enExample)
CO (1) CO6210756A2 (enExample)
ES (1) ES2582655T3 (enExample)
IL (2) IL199170A (enExample)
IN (1) IN2009CN03372A (enExample)
MX (1) MX2009006470A (enExample)
NZ (1) NZ578352A (enExample)
RU (2) RU2457217C2 (enExample)
UA (3) UA120027C2 (enExample)
WO (1) WO2008076255A2 (enExample)
ZA (1) ZA200904152B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101631800B (zh) 2006-12-14 2012-12-05 先灵-普劳有限公司 犬胸腺基质淋巴细胞生成素蛋白及其应用
JP5492158B2 (ja) 2011-08-24 2014-05-14 富士フイルム株式会社 ヒトｔｓｈ及び犬ｔｓｈに対する抗体
US9546219B2 (en) 2012-02-08 2017-01-17 North Carolina State University Treatment of allergic diseases with recombinant antibodies
AR090915A1 (es) 2012-05-04 2014-12-17 Intervet Int Bv Proteina de fusion de proteina linfopoyetina estromal timica canina con la region fc de igg
WO2014162007A2 (en) * 2013-04-04 2014-10-09 Ieo - Istituto Europeo Di Oncologia Srl Thymic stromal lymphopoietin fragments and uses thereof
AR097293A1 (es) * 2013-08-09 2016-03-02 Astellas Pharma Inc Anticuerpo contra el receptor de tslp humana
RU2732604C2 (ru) 2013-12-20 2020-09-21 Интервет Интернэшнл Б.В. Антитела к pd-1 собак
WO2015118124A1 (en) * 2014-02-06 2015-08-13 Vib Vzw Thymic stromal lymphopoietin receptor antagonist
RU2736732C2 (ru) 2015-04-02 2020-11-19 Интервет Интернэшнл Б.В. Антитела к альфа-рецептору собачьего интерлейкина-4
EA038332B1 (ru) 2015-09-09 2021-08-10 Новартис Аг Молекулы, связывающиеся с тимусным стромальным лимфопоэтином (tslp), и способы применения таких молекул
RU2731644C2 (ru) 2015-09-09 2020-09-07 Новартис Аг Молекулы, связывающиеся с тимусным стромальным лимфопоэтином (tslp), и способы применения таких молекул
CA3005696A1 (en) 2015-12-18 2017-06-22 Intervet International B.V. Caninized human antibodies to human and canine il-4r alpha
US11091556B2 (en) 2015-12-18 2021-08-17 Intervet Inc. Caninized human antibodies to human IL-4R alpha
WO2018089335A1 (en) 2016-11-09 2018-05-17 North Carolina State University Treatment of allergic diseases with chimeric protein
WO2019183437A1 (en) 2018-03-23 2019-09-26 North Carolina State University Methods and compositions for antibody to high affinity receptor for ige
CN115028722B (zh) * 2021-03-05 2024-09-03 拜西欧斯（北京）生物技术有限公司 抗tslp抗体及其制备方法和用途

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4281061A (en) * 1979-07-27 1981-07-28 Syva Company Double antibody for enhanced sensitivity in immunoassay
ZA887773B (en) 1987-10-26 1989-07-26 Immunex Corp Interleukin-7
US5714585A (en) * 1987-10-26 1998-02-03 Sterling Winthrop, Inc. Antibodies that are immunoreactive with interleukin-7
US5413914A (en) * 1993-07-07 1995-05-09 The Regents Of The University Of Colorado Yeast assay to identify inhibitors of dibasic amino acid processing endoproteases
US6844170B1 (en) * 1998-03-19 2005-01-18 Human Genome Sciences, Inc. Cytokine receptor common gamma chain like
US20030099947A1 (en) * 1998-09-21 2003-05-29 Bazan J. Fernando Mammalian cytokines; related reagents and methods
IL143034A0 (en) * 1998-11-13 2002-04-21 Immunex Corp Human tslp dna and polypeptides
WO2000039149A2 (en) 1998-12-30 2000-07-06 Millennium Pharmaceuticals, Inc. Secreted proteins and uses thereof
GB9908533D0 (en) * 1999-04-14 1999-06-09 Novartis Ag Organic compounds
JP2004519205A (ja) * 2000-06-28 2004-07-02 アムジェン インコーポレイテッド 胸腺間質リンホポイエチンレセプター分子およびその使用
US6890734B2 (en) * 2000-11-10 2005-05-10 Schering Corporation Nucleic acids encoding a cytokine receptor complex
CA2532595A1 (en) * 2003-07-18 2005-01-27 Schering Corporation Treatment and diagnosis of neoplasms using thymic stromal lymphopoietin
US20090156467A1 (en) * 2004-07-28 2009-06-18 Zhengbin Yao Thymic stromal lymphpoietin promoter and use therefor
SE532251C2 (sv) 2006-11-28 2009-11-24 Theravac Pharmaceuticals Ab Nya formuleringar av TSLP för behandling av TH2-medierade inflammatoriska sjukdomar genom vaccinering
CN101631800B (zh) * 2006-12-14 2012-12-05 先灵-普劳有限公司 犬胸腺基质淋巴细胞生成素蛋白及其应用

Also Published As

Publication number Publication date
RU2617957C2 (ru) 2017-04-28
US20130183291A1 (en) 2013-07-18
RU2012113162A (ru) 2013-10-20
RU2457217C2 (ru) 2012-07-27
US20080152620A1 (en) 2008-06-26
IL215507A0 (en) 2011-11-30
JP2013048637A (ja) 2013-03-14
WO2008076255A3 (en) 2008-09-18
UA108064C2 (uk) 2015-03-25
CO6210756A2 (es) 2010-10-20
AU2007334531B2 (en) 2012-04-12
JP2012090647A (ja) 2012-05-17
CN102584998A (zh) 2012-07-18
UA120027C2 (uk) 2019-09-25
US8076456B2 (en) 2011-12-13
CA2671865A1 (en) 2008-06-26
RU2009126617A (ru) 2011-01-20
JP6117767B2 (ja) 2017-04-19
JP5707380B2 (ja) 2015-04-30
CN101631800B (zh) 2012-12-05
EP2104683B1 (en) 2016-05-25
WO2008076255A2 (en) 2008-06-26
US7718772B2 (en) 2010-05-18
US20110033478A1 (en) 2011-02-10
CA2671865C (en) 2017-01-10
CN102584998B (zh) 2017-07-04
ZA200904152B (en) 2011-11-30
AU2007334531A1 (en) 2008-06-26
ES2582655T3 (es) 2016-09-14
KR101525631B1 (ko) 2015-06-04
EP2104683A2 (en) 2009-09-30
IN2009CN03372A (enExample) 2015-08-07
US8791242B2 (en) 2014-07-29
JP2010512744A (ja) 2010-04-30
CN101631800A (zh) 2010-01-20
KR20090097921A (ko) 2009-09-16
BRPI0720001A2 (pt) 2013-12-24
UA95329C2 (ru) 2011-07-25
JP2015107121A (ja) 2015-06-11
IL199170A (en) 2015-04-30
NZ578352A (en) 2012-05-25

Similar Documents

Publication Publication Date Title
MX2009006470A (es) Proteina linfopoyetina estromatica timica de canino, y usos de la misma.
JO3351B1 (ar) بروتينات رابطة مستضِدة قادرة على ربط مكونات ليمفاوية سدوية سُعترية الشكل
MY162752A (en) Alpha-4-beta-7 heterodimer specific antagonist antibody
MX359903B (es) Proteínas estructurales de una mutación del parvovirus como vacunas.
WO2011032161A8 (en) Vaccines directed to langerhans cells
WO2007106476A3 (en) Compositions and methods for enhancing the immunogenicity of antigens
WO2008006554A3 (en) Glyco-engineered antibodies
WO2010104747A3 (en) Antigen presenting cell targeted vaccines
CU24058B1 (es) Antagonistas de pcsk9
WO2010046775A3 (en) Methods for producing antibodies from plasma cells
WO2008005880A3 (en) Antibodies for norovirus
NZ601615A (en) Antibodies that bind to lysyl oxidase-like 2 (loxl2) and methods of use therefor
WO2008098917A3 (en) Novel antibodies against igf-ir
MX2009013824A (es) Proteinas de enlace de antigeno que enlazan par-2.
GB201003701D0 (en) System for the expression of a protein
WO2009109368A8 (en) Identification of antigen- or ligand-specific binding proteins
MX2009008754A (es) Anticuerpos novedosos contra igf-1r.
WO2007127372A3 (en) Genetic adjuvants for viral vaccines
WO2006108033A3 (en) Recombinant antigens for the detection of coxiella burnetii
UA100531C2 (ru) Антитело, которое специфически связывается с тимическим стромальным лимфопоэтином (tslp)
MX2009011851A (es) Plasmidos de dna que tienen expresion y estabilidad mejoradas.
WO2005092922A3 (de) Antigen des pm-2 antikörpers und dessen verwendung
DE602005010680D1 (de) Zusammensetzungen und verfahren zur induktion einer antitumorimmunität
WO2023067031A3 (en) In vitro potency assay for protein-based meningococcal vaccines using a plurality of monoclonal antibodies and antigens immobilized to colour-coded beads
WO2009086333A3 (en) Methods and compositions relatin to antibodies that bind a protein reticulon 3

Legal Events

Date Code Title Description
FG Grant or registration